Acute Kidney Injury (AKI) Disease Treatment Market Size, Growth, In-depth Analysis, Research Report Forecast up to 2027: RenalGuard Solutions, Inc. and Exponential Biotherapies, Inc. are key players.

The Acute Kidney Injury (AKI) Disease Treatment Market is expected to grow at a CAGR of 2.07% to reach a market size worth US$34.596 billion by 2027.

The prime factors propelling the growth of the acute kidney injury (AKI) disease treatment market are the growing elderly population raising the demand for acute kidney disease treatment.

As per the report, the acute kidney injury (AKI) disease treatment market is expected to grow steadily over the forecast period.

Acute kidney failure is a sudden loss of the kidney's capacity to filter waste and assist in the body's electrolyte and fluid equilibrium. In addition, renal function is hampered by acute renal inflammation. Some of the reasons are reduced blood flow, autoimmune kidney disease, obstruction of the urinary tract, blood clotting in the blood vessels of the kidneys, and pregnancy complications. Urine analysis, which examines a urine sample's physical, microscopic, and chemical characteristics, is the most frequently used test to identify acute renal disease. RRT (Renal Replacement Therapy) and dialysis are the two most commonly used kidney-healing procedures. Additionally, the demand for treatment for acute kidney illness is rising as the population of the elderly rises, which will boost the acute kidney injury (AKI) disease treatment market.

Sample request or complete report can be purchased through the link below:
https://www.knowledge-sourcing.com/report/acute-kidney-injury-aki-disease-treatment-market

The carbon monoxide detectors market has been categorized based on diagnosis, type of RRT, and geography.

The market has been classified by diagnosis based on urine tests, blood tests, glomerular filtration rate (GFR), imaging tests, and kidney biopsy. The blood test has a significant market share as the doctor recommends a blood test to analyze and check for renal failure in the early stages of treatment. Increasing R&D efforts to create novel products are anticipated to accelerate market growth during the forecast period considerably. For instance, in January 2020, the German company SphingoTec GmbH debuted its IB10 sphingotest penKid, a Point-of-Care (PoC) test for Proenkephalin. (penKid) This biomarker makes it possible to assess kidney health in real-time using a routine blood test.

Based on the type of RRT, the classification has been done into continuous and intermittent. Continuous RRT is expected to have a significant market share as it has increased in popularity, and treatment facilities are driving towards continuous RRT. Compared to CRRT treatment, IHD may cause the renal recovery process to take longer in severely ill and unstable patients. In contrast, continuous RRT will take less time, boosting the market for acute kidney injury disease treatment.

By region, North America is expected to retain a considerable market share due to the growing number of people experiencing kidney failure. The leading causes are alcoholic habits, diabetes, and high blood pressure among the elderly, which increases the risk of acute kidney failure in the area. According to the CDC (Centers for Disease Control and Prevention), 37.3 million individuals in the United States have diabetes, and 28.7 million have been diagnosed.

The major players operating in the acute kidney injury (AKI) disease treatment market are Exponential Biotherapies, Inc., NIKKISO AMERICA, INC., AM-Pharma, RenalGuard Solutions, Inc., Angion Biomedica Corp., AtoxBio, Sentien Biotechnologies, Inc. and Baxter.

This Acute Kidney Injury (AKI) Disease Treatment Market has been analyzed into the following segments:

• By Diagnosis

o Urine Tests
o Blood Tests
o Glomerular Filtration Rate (GFR)
o Imaging tests
o Kidney Biopsy

• By Type of RRT

o Continuous
o Intermittent

• By Geography

o North America

• USA
• Canada
• Mexico

o South America

• Brazil
• Argentina
• Others

o Europe

• Germany
• France
• United Kingdom
• Others

o The Middle East and Africa

• Saudi Arabia
• UAE
• Others

o Asia Pacific

• China
• India
• Japan
• South Korea
• Thailand
• Taiwan
• Indonesia
• Others

Related Reports:

• https://www.knowledge-sourcing.com/report/melanoma-treatment-market
• https://www.knowledge-sourcing.com/report/eosinophilic-esophagitis-disease-treatment-market
• https://www.knowledge-sourcing.com/report/gaucher-disease-treatment-market
• https://www.knowledge-sourcing.com/report/global-organ-transplant-market

Contact Us:

Knowledge Sourcing Intelligence
Phone: +1-850-250-1698
E-Mail:info@knowledge-sourcing.com
Web: https://www.knowledge-sourcing.com/
Blogs: https://www.knowledge-sourcing.com/resources/blogs/
Follow Us: https://www.linkedin.com/company/knowledge-sourcing-intelligence

Knowledge Sourcing Intelligence (KSI) is a market research and consulting firm publishing market research studies across ten industry verticals. KSI has a team of experienced and young professionals who focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports annually centering on the niche and latest technologies. In addition, we engage with key decision-makers and stakeholders across the value chain to provide clients with a detailed analysis and bird's-eye view of the market with complete market dynamics, statistical forecasts, competitive analysis, key trends, market drivers, and challenges, and strategic recommendations for making informed decisions. Our success lies in our analysts' efforts to meet client expectations by delivering quality work within the stipulated deadlines.

This release was published on openPR.